Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals

Sophy Denker; Aitomi Bittner; Mareike Frick; Julia Kase; Jörg Hoffmann; Corinna Trenker; Ulrich Keller; Christian Bogner; Andreas Hüttmann; Clemens Schmitt; null et al.

doi:10.1080/10428194.2021.1964024

Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals

Sophy Denker, Aitomi Bittner, Mareike Frick, Julia Kase, Jörg Hoffmann, Corinna Trenker, Ulrich Keller, Christian Bogner, Andreas Hüttmann, Clemens Schmitt, et al.

Department of Internal Medicine 3 - Hematology and Internal Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-9
Number of pages	9
Journal	Leukemia and Lymphoma
DOIs	https://doi.org/10.1080/10428194.2021.1964024
Publication status	Published - Aug 2021

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2021.1964024

Cite this

Denker, S., Bittner, A., Frick, M., Kase, J., Hoffmann, J., Trenker, C., Keller, U., Bogner, C., Hüttmann, A., Schmitt, C., & et al. (2021). Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals. Leukemia and Lymphoma, 1-9. https://doi.org/10.1080/10428194.2021.1964024

@article{322642b618634a409d8b93ed97a44be9,

title = "Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals",

author = "Sophy Denker and Aitomi Bittner and Mareike Frick and Julia Kase and J{\"o}rg Hoffmann and Corinna Trenker and Ulrich Keller and Christian Bogner and Andreas H{\"u}ttmann and Clemens Schmitt and {et al.}",

year = "2021",

month = aug,

doi = "10.1080/10428194.2021.1964024",

language = "English",

pages = "1--9",

journal = "Leukemia and Lymphoma",

issn = "1029-2403",

}

Denker, S, Bittner, A, Frick, M, Kase, J, Hoffmann, J, Trenker, C, Keller, U, Bogner, C, Hüttmann, A, Schmitt, C & et al. 2021, 'Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals', Leukemia and Lymphoma, pp. 1-9. https://doi.org/10.1080/10428194.2021.1964024

TY - JOUR

T1 - Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals

AU - Denker, Sophy

AU - Bittner, Aitomi

AU - Frick, Mareike

AU - Kase, Julia

AU - Hoffmann, Jörg

AU - Trenker, Corinna

AU - Keller, Ulrich

AU - Bogner, Christian

AU - Hüttmann, Andreas

AU - Schmitt, Clemens

AU - et al., null

PY - 2021/8

Y1 - 2021/8

U2 - 10.1080/10428194.2021.1964024

DO - 10.1080/10428194.2021.1964024

M3 - Article

SN - 1029-2403

SP - 1

EP - 9

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

ER -